Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer

被引：0
|
作者：
Mansure, Jose [1 ]
Nassim, Roland [1 ]
Rocha, Joice [1 ]
Scarlata, Eleonora [1 ]
Chevalier, Simone [1 ]
Kassouf, Wassim [1 ]
机构：
[1] McGill, Montreal, PQ, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2879
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer
    Mansure, Jose J.
    Nassim, Roland
    Chevalier, Simone
    Rocha, Joice
    Scarlata, Eleonora
    Kassouf, Wassim
    CANCER BIOLOGY & THERAPY, 2009, 8 (24) : 2339 - 2347
  • [2] Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies
    Garcia, Jorge A.
    Danielpour, David
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (06) : 1347 - 1354
  • [3] Novel therapeutic strategy for breast cancer: mammalian target of rapamycin inhibition
    Yip, Adrian Yun-San
    Ong, Eleanor Yuen-Yuen
    Chow, Louis Wing-Cheong
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (04) : 457 - 466
  • [4] Inhibition of mammalian target of rapamycin (mTOR) signaling by Temsirolimus as a potential therapeutic strategy for esophageal cancer treatment
    Takaoka, Munenori
    Nishikawa, Toshio
    Ohara, Toshiaki
    Tomono, Yasuko
    Fujiwara, Yasuhiro
    Shirakawa, Yasuhiro
    Nagatsuka, Hitoshi
    Fukazawa, Takuya
    Yamatsuji, Tomoki
    Bao, Xiaohong
    Hao, Huifang
    Shigemitsu, Kaori
    Morita, Ichiro
    Fujiwara, Toshiyoshi
    Naomoto, Yoshio
    CANCER RESEARCH, 2011, 71
  • [5] Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy
    Alain Ndayisaba
    Gregor K. Wenning
    Clinical Autonomic Research, 2020, 30 : 7 - 8
  • [6] Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy
    Ndayisaba, Alain
    Wenning, Gregor K.
    CLINICAL AUTONOMIC RESEARCH, 2020, 30 (01) : 7 - 8
  • [7] Mammalian target of rapamycin inhibition
    Dutcher, JP
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6382S - 6387S
  • [8] Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
    Da-zhi Xu
    Qi-rong Geng
    Ying Tian
    Mu-yan Cai
    Xin-juan Fang
    You-qing Zhan
    Zhi-wei Zhou
    Wei Li
    Ying-bo Chen
    Xiao-wei Sun
    Yuan-xiang Guan
    Yuan-fang Li
    Tong-yu Lin
    BMC Cancer, 10
  • [9] Mammalian target of rapamycin (mTOR) as a target for cancer therapeutic development.
    Dancey, J
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3823S - 3824S
  • [10] Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
    Xu, Da-zhi
    Geng, Qi-rong
    Tian, Ying
    Cai, Mu-yan
    Fang, Xin-juan
    Zhan, You-qing
    Zhou, Zhi-wei
    Li, Wei
    Chen, Ying-bo
    Sun, Xiao-wei
    Guan, Yuan-xiang
    Li, Yuan-fang
    Lin, Tong-yu
    BMC CANCER, 2010, 10
12345